Lv5
820 积分 2024-11-22 加入
The RAvIN Platform: A Noncarbohydrate Platform for Oligonucleotide Synthesis
2天前
已完结
Advances in the pharmaceutical development of antibody-oligonucleotide conjugates
12天前
已完结
Oligonucleotide Purification by Ion Exchange Chromatography: A Step-by-Step Guide to Process Understanding, Modeling, and Simulation
24天前
已完结
Introduction to Quality by Design (QbD)
2个月前
已完结
Side Reactions in Peptide Synthesis
2个月前
已完结
Continuous Biopharmaceutical Processes
3个月前
已完结
NMR characterization of the diastereomeric composition of a model therapeutic oligonucleotide
3个月前
已完结
Emerging trends in the characterization of oligonucleotide diastereomers
3个月前
已完结
LBP-014 HBsAg loss and seroconversion after 16-week or 24-week AHB-137 treatment in HBeAg-negative chronic hepatitis B participants on NA therapy: results from an ongoing multicenter, randomized phase IIb study
3个月前
已完结
LBP-043 A phase 1, dose-escalation and dose-expansion study evaluating the safety, tolerability, pharmacokinetics and preliminary efficacy of AHB-137 in Chinese healthy volunteers and subjects with chronic hepatitis B
3个月前
已完结
皖公网安备34019202002308
